PRECEDEX

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Ecuador, Hong Kong SAR China, Japan, Mexico, New Zealand, Singapore, South Africa.

Active ingredients

The drug PRECEDEX contains one active pharmaceutical ingredient (API):

1	Dexmedetomidine UNII 1018WH7F9I - DEXMEDETOMIDINE HYDROCHLORIDE
	Dexmedetomidine is a selective alpha-2 receptor agonist with a broad range of pharmacological properties. It has a sympatholytic effect through decrease of the release of noradrenaline in sympathetic nerve endings. The sedative effects are mediated through decreased firing of locus coeruleus, the predominant noradrenergic nucleus, situated in the brainstem.
	Read more about Dexmedetomidine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PRECEDEX Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05CM18	Dexmedetomidine	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CM Other hypnotics and sedatives
Discover more medicines within N05CM18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	522717100060208, 522720100090007
CA	Health Products and Food Branch	02339366, 02437147
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.771-1-03-12
HK	Department of Health Drug Office	49806, 66360
JP	医薬品医療機器総合機構	1129400A1054, 1129400G1022
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	207M2000
NZ	Medicines and Medical Devices Safety Authority	19226, 19258, 19259, 8960
SG	Health Sciences Authority	11333P, 15689P
US	FDA, National Drug Code	0409-1434, 0409-1638, 0409-1660, 52584-638
ZA	Health Products Regulatory Authority	34/2.9/0239